Literature DB >> 28474352

Airway basophils are increased and activated in eosinophilic asthma.

Y Suzuki1, K Wakahara1, T Nishio1, S Ito1, Y Hasegawa1.   

Abstract

BACKGROUND: The impact of basophils on asthma pathogenesis remains largely unexplored, particularly in humans. Here, we evaluated the frequencies and activation status of basophils in the sputum of adult asthmatic patients and related our findings to other parameters of eosinophilic airway inflammation.
METHODS: We enrolled 44 adult asthmatic patients who were being treated with inhaled corticosteroids (ICS). Analysis of the induced sputum, exhaled nitric oxide fraction (FeNO) measurement, and asthma control test (ACT) were carried out together with standard blood and pulmonary function tests. The cellular composition of the sputum was examined by flow cytometry, and the phenotypes of blood and sputum basophils were compared.
RESULTS: Basophils were increased in the sputum of asthmatic patients. The expression of CD203c on sputum basophils was significantly higher than that on blood basophils. The percentage of sputum basophils was positively correlated with those of eosinophils and mast cells; it was also correlated with that of blood eosinophils and FeNO. However, sputum basophils were not correlated with serum IgE, lung function, or the percentage of blood basophils. A receiver-operating characteristic (ROC) curve showed the superiority of sputum basophils as a surrogate marker of the percentages of sputum eosinophils compared with absolute numbers of blood eosinophils and FeNO.
CONCLUSION: The number of activated basophils was increased in the sputum of patients with eosinophilic asthma and correlated with airway and blood eosinophils. Our observations suggest that sputum basophils may serve as a biomarker to monitor new therapeutic approaches for the treatment of eosinophilic asthma.
© 2017 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Entities:  

Keywords:  basophils; biomarker; eosinophilic asthma; sputum

Mesh:

Substances:

Year:  2017        PMID: 28474352     DOI: 10.1111/all.13197

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  12 in total

Review 1.  Role of myeloid cells in the regulation of group 2 innate lymphoid cell-mediated allergic inflammation.

Authors:  Aihua Lei; Yumei He; Qiong Yang; Xiaofang Li; Ranhui Li
Journal:  Immunology       Date:  2020-08-03       Impact factor: 7.397

Review 2.  Mast Cell-Mediated Orchestration of the Immune Responses in Human Allergic Asthma: Current Insights.

Authors:  Daniel Elieh Ali Komi; Leif Bjermer
Journal:  Clin Rev Allergy Immunol       Date:  2019-04       Impact factor: 8.667

Review 3.  Diagnostic Accuracy of Liquid Biomarkers in Airway Diseases: Toward Point-of-Care Applications.

Authors:  Vivianne Landry; Patrick Coburn; Karen Kost; Xinyu Liu; Nicole Y K Li-Jessen
Journal:  Front Med (Lausanne)       Date:  2022-06-06

4.  Risk Factors Predicting Severe Asthma Exacerbations in Adult Asthmatics: A Real-World Clinical Evidence.

Authors:  Ga Young Ban; Su Chin Kim; Hyun Young Lee; Young Min Ye; Yoo Seob Shin; Hae Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2021-05       Impact factor: 5.764

Review 5.  Important and specific role for basophils in acute allergic reactions.

Authors:  P Korošec; B F Gibbs; M Rijavec; A Custovic; P J Turner
Journal:  Clin Exp Allergy       Date:  2018-03-23       Impact factor: 5.018

Review 6.  Highlights and recent developments in airway diseases in EAACI journals (2017).

Authors:  J Bousquet; C A Akdis; C Grattan; P A Eigenmann; K Hoffmann-Sommergruber; P W Hellings; I Agache
Journal:  Clin Transl Allergy       Date:  2018-11-27       Impact factor: 5.871

7.  Mepolizumab does not alter the blood basophil count in severe asthma.

Authors:  Adam Kelvin Alec Wright; Sarah Diver; Jamie McCarthy; Andrew Marvin; Marcia Soares; Tracy Thornton; Michelle Bourne; Michelle Craner; Helen Evans; Sarah Edwards; Sarah Glover; Liesl Carr; Sarah Parker; Salman Siddiqui; David Cousins; Chris Brightling
Journal:  Allergy       Date:  2019-06-28       Impact factor: 13.146

8.  Clinical Differences between Early- and Late-Onset Asthma: A Population-Based Cross-Sectional Study.

Authors:  Jiaming Li; Ling Ye; Jun She; Yuanlin Song
Journal:  Can Respir J       Date:  2021-01-12       Impact factor: 2.409

9.  Molecular Analysis of IL-5 Receptor Subunit Alpha as a Possible Pharmacogenetic Biomarker in Asthma.

Authors:  Sandra Elena-Pérez; David Hansoe Heredero-Jung; Asunción García-Sánchez; Miguel Estravís; Maria J Martin; Jacinto Ramos-González; Juan Carlos Triviño; María Isidoro-García; Catalina Sanz; Ignacio Dávila
Journal:  Front Med (Lausanne)       Date:  2021-02-11

10.  Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report.

Authors:  C Caruso; S Colantuono; D Pugliese; C Di Mario; B Tolusso; E Gremese; G Papparella; F Castrì; A Gasbarrini; A Romano; A Armuzzi
Journal:  Allergy Asthma Clin Immunol       Date:  2020-04-22       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.